CY1085A - 1,8-naphthyridine derivatives - Google Patents

1,8-naphthyridine derivatives

Info

Publication number
CY1085A
CY1085A CY1085A CY108576A CY1085A CY 1085 A CY1085 A CY 1085A CY 1085 A CY1085 A CY 1085A CY 108576 A CY108576 A CY 108576A CY 1085 A CY1085 A CY 1085A
Authority
CY
Cyprus
Prior art keywords
naphthyridine derivatives
naphthyridine
derivatives
Prior art date
Application number
CY1085A
Other languages
English (en)
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7510756A external-priority patent/FR2321290A1/fr
Priority claimed from FR7603773A external-priority patent/FR2340733A2/fr
Priority claimed from FR7603774A external-priority patent/FR2340731A1/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of CY1085A publication Critical patent/CY1085A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/54—Preparation of carboxylic acid anhydrides
    • C07C51/56—Preparation of carboxylic acid anhydrides from organic acids, their salts, their esters or their halides, e.g. by carboxylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY1085A 1975-04-07 1976-04-05 1,8-naphthyridine derivatives CY1085A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR7510756A FR2321290A1 (fr) 1975-04-07 1975-04-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7603773A FR2340733A2 (fr) 1976-02-11 1976-02-11 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7603774A FR2340731A1 (fr) 1976-02-11 1976-02-11 Nouveaux composes heterocycliques, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
CY1085A true CY1085A (en) 1980-12-27

Family

ID=27250439

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1085A CY1085A (en) 1975-04-07 1976-04-05 1,8-naphthyridine derivatives

Country Status (29)

Country Link
US (1) US4086348A (enExample)
JP (1) JPS51122094A (enExample)
AR (3) AR214286A1 (enExample)
AT (1) AT348524B (enExample)
CA (1) CA1072957A (enExample)
CH (2) CH613453A5 (enExample)
CS (3) CS186747B2 (enExample)
CY (1) CY1085A (enExample)
DD (1) DD123605A5 (enExample)
DE (1) DE2615067A1 (enExample)
DK (1) DK162976A (enExample)
ES (2) ES446762A1 (enExample)
FI (1) FI60012C (enExample)
GB (1) GB1483996A (enExample)
HK (1) HK54580A (enExample)
HU (1) HU176315B (enExample)
IE (1) IE42973B1 (enExample)
IL (1) IL49344A (enExample)
LU (1) LU74703A1 (enExample)
MX (1) MX3138E (enExample)
NL (1) NL7603307A (enExample)
NO (1) NO144019C (enExample)
OA (1) OA05287A (enExample)
PH (1) PH14015A (enExample)
PL (3) PL100988B1 (enExample)
PT (1) PT64976B (enExample)
SE (2) SE7604044L (enExample)
SU (3) SU648102A3 (enExample)
YU (3) YU86976A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265803A (fr) * 1985-07-11 1990-02-13 Claude Cotrel Amides substitues, leur preparation et les medicaments qui les contiennent
DE10042093A1 (de) * 2000-08-26 2002-03-07 Dresden Arzneimittel Antikonvulsiv wirkende 6,7-Dihydro-pyrrolo[3,4-d]pyridin-5-one und Verfahren zu deren Darstellung
CN100548980C (zh) * 2002-11-26 2009-10-14 丸石制药株式会社 异吲哚啉衍生物
WO2007080430A1 (en) * 2006-01-16 2007-07-19 Generics [Uk] Limited Novel process
US9682967B2 (en) 2013-01-28 2017-06-20 H. Lundbeck A/S N-substituted-5-substituted phthalamic acids as sortilin inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
FI60012B (fi) 1981-07-31
AR214055A1 (es) 1979-04-30
CH614209A5 (en) 1979-11-15
HK54580A (en) 1980-10-03
PT64976B (fr) 1977-09-07
CS186748B2 (en) 1978-12-29
CS186747B2 (en) 1978-12-29
ES446762A1 (es) 1977-06-01
SE421793B (sv) 1982-02-01
YU130582A (en) 1983-02-28
US4086348A (en) 1978-04-25
AR213739A1 (es) 1979-03-15
DK162976A (da) 1976-10-08
IL49344A0 (en) 1976-06-30
CS186734B2 (en) 1978-12-29
IL49344A (en) 1979-05-31
OA05287A (fr) 1981-02-28
SU637082A3 (ru) 1978-12-05
PL100987B1 (pl) 1978-11-30
AR214286A1 (es) 1979-05-31
JPS51122094A (en) 1976-10-25
YU130482A (en) 1983-02-28
ES448847A1 (es) 1977-10-01
NO144019B (no) 1981-02-23
IE42973B1 (en) 1980-11-19
YU86976A (en) 1983-02-28
JPS62149B2 (enExample) 1987-01-06
GB1483996A (en) 1977-08-24
NO761168L (enExample) 1976-10-08
HU176315B (en) 1981-01-28
PL100988B1 (pl) 1978-11-30
PL100184B1 (pl) 1978-09-30
SU638258A3 (ru) 1978-12-15
ATA249776A (de) 1978-07-15
FI760937A7 (enExample) 1976-10-08
MX3138E (es) 1980-05-06
PH14015A (en) 1980-12-08
AT348524B (de) 1979-02-26
DD123605A5 (enExample) 1977-01-05
IE42973L (en) 1976-10-07
LU74703A1 (enExample) 1977-02-02
PT64976A (fr) 1976-05-01
NL7603307A (nl) 1976-10-11
FI60012C (fi) 1981-11-10
DE2615067A1 (de) 1976-10-28
SE7604044L (sv) 1976-10-08
SU648102A3 (ru) 1979-02-15
AU1267476A (en) 1977-10-13
CH613453A5 (enExample) 1979-09-28
NO144019C (no) 1981-06-03
CA1072957A (fr) 1980-03-04

Similar Documents

Publication Publication Date Title
PH13772A (en) 1,4-dihydropyridine derivatives
NZ182429A (en) 2 phenyl-3-aroylbenzothiophene derivatives
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
NZ182756A (en) 2-or3-amino-c-substituted-imidazo(1,2-a) pyridines
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
GB1532697A (en) 2,3-dihydroergolines
AU512383B2 (en) Thinenamycin derivatives
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
GB1557694A (en) 2,9 dichlorquinacridone
PH14168A (en) 2,4-pyrrolidinediones
GB1483996A (en) 1,8-naphthyridine derivatives
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
GB1554021A (en) 4,5-didehydroprostaglandins
AU502308B2 (en) Naphthyridine derivatives
PH14888A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative
GB1554925A (en) 2,3-methyl-eneprostaglandins
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU1483576A (en) 16,16-dimethyl-prostaglandins
IL48972A (en) 5-substituted-triazolo (3,4-b)(1,3,4)-cycloalkathiadiazine derivatives
AU476721B2 (en) Naphthyridine derivatives
GB1551409A (en) 3,5-diphenylpyridazine derivatives
NZ179990A (en) 2-aminomethylene-1,2-dihydor-4h-imidazo (1,2-a) (1,4)-benzodiazepin-1-ones